GLP-1 receptor agonists like Ozempic have become some of the most prescribed medications in the United States, yet millions of Medicare beneficiaries remain unsure whether their plan will pick up the tab. If you’re asking does Medicare cover Ozempic, the answer depends on why your doctor prescribes it and which part of Medicare you carry. Recent legislative changes have shifted the landscape significantly heading into 2026, making this a question worth revisiting even if you checked last year.
Understanding Ozempic and Why It Matters for Medicare
Ozempic (semaglutide) is an injectable GLP-1 receptor agonist manufactured by Novo Nordisk. The FDA originally approved it in 2017 for the treatment of type 2 diabetes, where it helps lower blood sugar levels and reduce A1C. Since then, semaglutide has gained enormous popularity for its weight-loss effects, though Ozempic itself is not FDA-approved for weight management alone — that indication belongs to its higher-dose sibling, Wegovy.
For Medicare enrollees, this distinction between diabetes treatment and weight loss is critical. Traditional Medicare has historically excluded coverage for drugs prescribed solely for weight loss. However, the Treat and Reduce Obesity Act and provisions within the Inflation Reduction Act have begun reshaping these rules, and 2026 brings further changes that directly affect whether does Medicare cover Ozempic for you.
Medicare Part D Coverage for Ozempic in 2026
Medicare Part D is the outpatient prescription drug benefit, and it’s the primary pathway through which beneficiaries access Ozempic. When prescribed for type 2 diabetes — its FDA-approved indication — most Part D plans include Ozempic on their formularies. That said, placement on the formulary tier varies by plan, and your out-of-pocket cost depends heavily on which tier your plan assigns it to.
Starting in 2025, the Inflation Reduction Act capped annual out-of-pocket prescription drug spending under Part D at $2,000. This cap remains in effect for 2026 and provides significant relief for beneficiaries taking expensive medications like Ozempic, which can cost over $900 per month without insurance. If you hit that $2,000 ceiling, you pay nothing more for covered drugs for the rest of the year.
Keep in mind that Part D plans can require prior authorization or step therapy before approving Ozempic. Your prescriber may need to document that you’ve tried metformin or other first-line diabetes medications before the plan agrees to cover a GLP-1. Check your plan’s formulary at Medicare.gov Plan Compare for specifics.
Does Medicare Cover Ozempic for Weight Loss?
This is where things get complicated. Medicare Part D has long excluded coverage for drugs used exclusively for weight loss. Ozempic is FDA-approved only for type 2 diabetes, so prescribing it off-label purely for weight management has traditionally meant Medicare won’t pay.
However, the legislative environment is evolving. The Treat and Reduce Obesity Act, which gained renewed momentum in Congress, aims to allow Medicare to cover FDA-approved anti-obesity medications. As of early 2026, certain Medicare Advantage plans have begun offering supplemental benefits that include obesity treatment drugs, though this varies widely by plan and geography.
If your physician prescribes Ozempic primarily for diabetes but you also benefit from weight loss, coverage generally applies. The key factor is the diagnosis code on the prescription claim. A type 2 diabetes diagnosis (ICD-10 code E11.x) typically triggers coverage, while an obesity-only diagnosis may not. Discuss coding with your doctor’s office to ensure claims are submitted correctly.
Medicare Advantage and GLP-1 Coverage
Medicare Advantage (Part C) plans, offered by private insurers like UnitedHealthcare, Humana, and Aetna, must cover everything Original Medicare covers — but they can also offer extra benefits. Some Medicare Advantage plans in 2026 have expanded their formularies to include broader GLP-1 access, and a growing number offer supplemental obesity-related benefits.
According to the Centers for Medicare & Medicaid Services (CMS), Medicare Advantage enrollment has continued climbing, with over 33 million beneficiaries in 2025. Many of these plans compete aggressively on drug benefits, meaning your GLP-1 coverage could be substantially better under an Advantage plan compared to Original Medicare with a standalone Part D plan.
During the Annual Election Period (October 15 through December 7), you can compare plans and switch to one that better covers your medications. Use the Medicare.gov plan finder tool to search specifically for Ozempic coverage in your area.
What You’ll Pay Out of Pocket for Ozempic
Even with Medicare coverage, Ozempic isn’t cheap. Without any insurance, a single monthly pen runs approximately $900 to $1,100 at most pharmacies. With Part D coverage, your cost depends on the plan’s tier structure.
- Preferred brand tier: Copays typically range from $40 to $100 per month
- Non-preferred brand tier: Copays or coinsurance may run $100 to $250 per month
- Specialty tier: Some plans place Ozempic here, with coinsurance of 25% to 33% until you reach the $2,000 cap
Thanks to the $2,000 annual out-of-pocket cap under the Inflation Reduction Act, even beneficiaries on expensive specialty-tier drugs will see their total yearly spending limited. Additionally, the Medicare Prescription Payment Plan allows you to spread your costs across monthly installments rather than paying large amounts at the pharmacy counter. Learn more about how drug pricing works in our healthcare policy guide.
Prior Authorization and Step Therapy Requirements
Most Medicare Part D plans require prior authorization before they’ll approve Ozempic. This means your doctor must submit documentation to the plan showing that the medication is medically necessary for your condition. Common requirements include:
- A confirmed diagnosis of type 2 diabetes
- Documentation of A1C levels (often above 7%)
- Evidence that you’ve tried and failed, or cannot tolerate, first-line treatments like metformin
- Sometimes, evidence that other GLP-1 options were considered
Step therapy — where the plan requires you to try cheaper alternatives first — is common with GLP-1 medications. If your prior authorization is denied, you have the right to appeal. The Medicare Part D appeals process allows you to request an expedited review, especially if your doctor believes a delay could harm your health.
Alternatives to Ozempic Covered by Medicare
If your plan doesn’t cover Ozempic or places it on an unfavorable tier, other GLP-1 medications may be available at a lower cost. Trulicity (dulaglutide), Victoza (liraglutide), and Rybelsus (oral semaglutide) are all FDA-approved for type 2 diabetes and covered by many Part D plans. Your doctor can help determine which medication best suits your clinical needs while keeping costs manageable.
Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist, is another option gaining traction. It received FDA approval for type 2 diabetes and has shown impressive results in clinical trials. Some Part D plans cover Mounjaro at a similar or lower tier than Ozempic. You can compare related side effects in our guide to Mounjaro side effects.
How to Save on Ozempic With Medicare
Beyond choosing the right plan, several strategies can reduce your Ozempic costs. Novo Nordisk offers a patient assistance program for eligible individuals, though Medicare beneficiaries may face restrictions on manufacturer copay cards due to federal anti-kickback laws. However, state pharmaceutical assistance programs (SPAPs) and the Medicare Extra Help/Low-Income Subsidy program can dramatically lower costs for qualifying enrollees.
If you have limited income and resources, the Extra Help program through Social Security can reduce Part D premiums, deductibles, and copayments. Beneficiaries who qualify may pay as little as $0 to $11.20 per prescription. Additionally, exploring Ozempic pricing options through different pharmacies using tools like GoodRx can sometimes reveal lower cash-price alternatives if coverage gaps exist.
Frequently Asked Questions
Does Medicare cover Ozempic for prediabetes?
Generally, no. Medicare Part D covers Ozempic for its FDA-approved indication of type 2 diabetes. Prediabetes is not currently an approved indication, and most plans will deny coverage for this diagnosis code. Your doctor may recommend lifestyle interventions or metformin, which is sometimes prescribed off-label for prediabetes prevention.
Can I get Ozempic through Medicare Part B instead of Part D?
Part B covers drugs administered in a doctor’s office or clinical setting, not self-administered injectables you take at home. Since Ozempic is a self-injected medication, it falls under Part D. In rare cases where a beneficiary receives it in a clinical setting, Part B might apply, but this is uncommon.
What happens if my Medicare plan denies Ozempic coverage?
You can file an appeal through the Part D appeals process. Start by asking your doctor to submit a coverage determination request with supporting medical documentation. If denied, you can escalate through multiple levels of appeal, including an independent review entity. Many initial denials are overturned on appeal.
Will Medicare cover Wegovy for weight loss in 2026?
As of early 2026, standard Medicare Part D still generally excludes drugs prescribed solely for weight loss. However, legislative efforts continue to push for expanded coverage of anti-obesity medications. Some Medicare Advantage plans may offer supplemental weight management benefits that include GLP-1 drugs. Check your specific plan details during open enrollment.
Bottom Line on Medicare and Ozempic Coverage
Whether does Medicare cover Ozempic for your situation comes down to your diagnosis, your specific plan, and how your claim is coded. For type 2 diabetes, most Part D plans provide coverage, though tier placement and prior authorization requirements vary. The $2,000 annual out-of-pocket cap offers meaningful financial protection regardless of which tier your plan assigns. Review your plan’s formulary annually, take advantage of the appeals process if needed, and explore assistance programs to keep your costs as low as possible.